Cytotoxic and apoptotic effects of ternary silver(i) complexes bearing 2-formylpyridine thiosemicarbazones and 1,10-phenanthroline. 2020

Débora E S Silva, and Amanda B Becceneri, and Mariana C Solcia, and João V B Santiago, and Mariete B Moreira, and José A Gomes Neto, and Fernando R Pavan, and Márcia R Cominetti, and José C M Pereira, and Adelino V G Netto
Department of General and Inorganic Chemistry, Department of Analytical Chemistry, UNESP - São Paulo State University, Institute of Chemistry, CEP 14800-060 Araraquara, SP, Brazil. deboraeduarda.soares@gmail.com adelino.netto@unesp.br.

New silver(i) compounds containing 2-formylpyridine-N(4)-R-thiosemicarbazones and 1,10-phenanthroline (phen) were synthesized and characterized by spectroscopic techniques (IR and NMR), elemental analysis, ESI-MS and molar conductance measurements. In these complexes, both phen and thiosemicarbazone ligands are coordinated in a chelating bidentate fashion. Compounds 1-3 not only showed good in vitro antiproliferative activity against human lung (A549) and breast tumor cells (MDA-MB-231 and MCF-7), with IC50 values ranging from 1.49 to 20.90 μM, but were also demonstrated to be less toxic towards human breast non-tumor cells (MCF-10A). Cellular uptake studies indicated that compounds 1-3 were taken up by the MDA-MB-231 cells in 6 hours. Cell death assays in the MDA-MB-231 cells were conducted with compound 1 aiming to evaluate its effects on cell morphology, induction of apoptosis, the cell cycle, reactive oxygen species (ROS) formation and mitochondrial membrane potential (Δψm). Compound 1 caused morphological changes, such as cell shrinkage and rounding, increased the sub-G1 phase population, and induced apoptotic cell death, ROS formation and loss of mitochondrial membrane potential (Δψm). DNA binding results revealed that 1 interacted with the ct-DNA minor groove. Complexes 1-3 also exhibited good in vitro activity against M. tuberculosis H37Rv, with MIC values ranging from 3.37 to 4.65 μM.

UI MeSH Term Description Entries
D010618 Phenanthrolines Phenanthroline
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072283 A549 Cells An immortalized cell line derived from human ADENOCARCINOMA, ALVEOLAR basal epithelial cells isolated from the lungs of a male patient in 1972. The cell line is positive for KERATIN, can synthesize LECITHIN, and contains high levels of POLYUNSATURATED FATTY ACIDS in its PLASMA MEMBRANE. It is used as a model for PULMONARY ALVEOLI function and virus infections, as a TRANSFECTION host, and for PRECLINICAL DRUG EVALUATION. A549 Cell Line,A549 Cell,A549 Cell Lines,Cell Line, A549,Cell Lines, A549,Cell, A549,Cells, A549
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012834 Silver An element with the atomic symbol Ag, atomic number 47, and atomic weight 107.87. It is a soft metal that is used medically in surgical instruments, dental prostheses, and alloys. Long-continued use of silver salts can lead to a form of poisoning known as ARGYRIA.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013882 Thiosemicarbazones Thiosemicarbazone

Related Publications

Débora E S Silva, and Amanda B Becceneri, and Mariana C Solcia, and João V B Santiago, and Mariete B Moreira, and José A Gomes Neto, and Fernando R Pavan, and Márcia R Cominetti, and José C M Pereira, and Adelino V G Netto
March 2024, Future microbiology,
Débora E S Silva, and Amanda B Becceneri, and Mariana C Solcia, and João V B Santiago, and Mariete B Moreira, and José A Gomes Neto, and Fernando R Pavan, and Márcia R Cominetti, and José C M Pereira, and Adelino V G Netto
January 2008, Acta crystallographica. Section E, Structure reports online,
Débora E S Silva, and Amanda B Becceneri, and Mariana C Solcia, and João V B Santiago, and Mariete B Moreira, and José A Gomes Neto, and Fernando R Pavan, and Márcia R Cominetti, and José C M Pereira, and Adelino V G Netto
November 2017, Dalton transactions (Cambridge, England : 2003),
Débora E S Silva, and Amanda B Becceneri, and Mariana C Solcia, and João V B Santiago, and Mariete B Moreira, and José A Gomes Neto, and Fernando R Pavan, and Márcia R Cominetti, and José C M Pereira, and Adelino V G Netto
September 2010, Acta crystallographica. Section E, Structure reports online,
Débora E S Silva, and Amanda B Becceneri, and Mariana C Solcia, and João V B Santiago, and Mariete B Moreira, and José A Gomes Neto, and Fernando R Pavan, and Márcia R Cominetti, and José C M Pereira, and Adelino V G Netto
January 2024, Molecules (Basel, Switzerland),
Débora E S Silva, and Amanda B Becceneri, and Mariana C Solcia, and João V B Santiago, and Mariete B Moreira, and José A Gomes Neto, and Fernando R Pavan, and Márcia R Cominetti, and José C M Pereira, and Adelino V G Netto
June 1981, Talanta,
Débora E S Silva, and Amanda B Becceneri, and Mariana C Solcia, and João V B Santiago, and Mariete B Moreira, and José A Gomes Neto, and Fernando R Pavan, and Márcia R Cominetti, and José C M Pereira, and Adelino V G Netto
October 2015, Dalton transactions (Cambridge, England : 2003),
Débora E S Silva, and Amanda B Becceneri, and Mariana C Solcia, and João V B Santiago, and Mariete B Moreira, and José A Gomes Neto, and Fernando R Pavan, and Márcia R Cominetti, and José C M Pereira, and Adelino V G Netto
July 2008, European journal of medicinal chemistry,
Débora E S Silva, and Amanda B Becceneri, and Mariana C Solcia, and João V B Santiago, and Mariete B Moreira, and José A Gomes Neto, and Fernando R Pavan, and Márcia R Cominetti, and José C M Pereira, and Adelino V G Netto
November 1970, Journal of medicinal chemistry,
Débora E S Silva, and Amanda B Becceneri, and Mariana C Solcia, and João V B Santiago, and Mariete B Moreira, and José A Gomes Neto, and Fernando R Pavan, and Márcia R Cominetti, and José C M Pereira, and Adelino V G Netto
June 2003, Journal of inorganic biochemistry,
Copied contents to your clipboard!